Patents: a necessary evil?
European Pharmaceutical Review
OCTOBER 19, 2022
2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” 23 April 2013. 3. [link]. Cited 25 September 2022]. Li-dar Wang R, Huang P-C.
96 
Let's personalize your content